Autoimmune Disease Diagnostics Market Size to Grow by $ 1.98 Billion  through 2021-2025 | Forecast and Trend Analysis

Technavio has been monitoring the autoimmune disease diagnostics market and it is expected to grow by $ 1.98 Billion, accelerating at a CAGR of almost 9% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking.

Autoimmune Disease Diagnostics Market: Receive Free Sample Report

Autoimmune Disease Diagnostics Market: Emerging Trends to Impact Market Growth

Growing consumer shift toward direct-to-consumer testing to emerge as a key trend in the autoimmune disease diagnostics market. One of the primary factors that will augment the growth of the autoimmune disease diagnostics market size is discovery of novel biomarkers leading to improved autoimmune diagnosis.

This report provides a detailed analysis of all the trends that are likely to influence the growth of individual segments within the market as well as the overall market in focus. This analysis will enable clients to assess their play in the market and plan for growth opportunities.

Autoimmune Disease Diagnostics Market: Vendor Analysis

The market is fragmented due to the presence of several players. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Abbott Laboratories, bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Hemagen Diagnostics Inc., HOB Biotech Group Corp., Quest Diagnostics Inc., Siemens AG, and Thermo Fisher Scientific Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.

Technavio custom reports provide market insights at the global and regional level along with a pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.

For more insights into this market: Download a Free Sample Report

The report provides insights into the following FAQs:

1. What is the market CAGR?
   The market is accelerate at a CAGR of almost 9%.
    
2. What is the incremental growth of the market?
   The market is expected to grow by $ 1.98 bn through 2021-2025.
    
3. What is a key factor driving this market?
   increasing M&A will drive market growth over the forecast period.
    
4. What are the key regions covered in this market research report?
   North America, Europe, Asia, and ROW are the key regions featured in this research report.
    
5. Which is the leading geographic region for this market:
   42% growth will originate from North America
    
6. Who are the leading market vendors?
   The leading vendors in this market are Abbott Laboratories, bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Hemagen Diagnostics Inc., HOB Biotech Group Corp., Quest Diagnostics Inc., Siemens AG, and Thermo Fisher Scientific Inc.
    
7. What are the market segments covered in this report?
   The market is segmented by Product (Assay kits and Analyzers), Type (Localized autoimmune disease diagnostics and Systemic autoimmune disease diagnostics), and Geography (North America, Europe, Asia, and ROW)